Influenza A virus (IAV)-induced impairment of neutrophil function or survival may be a cause of bacterial superinfection of IAV-infected subjects. This study was performed to determine the mechanism through which the combination of IAV and Escherichia coli co-operatively reduces neutrophil survival. Neutrophil binding of annexin-V and caspase-3 activation was significantly increased by either IAV or E. coli, supporting the concept that the micro-organisms accelerate neutrophil apoptosis. The anti-apoptotic agent granulocyte-macrophage colony stimulating factor (GM-CSF) did not improve, but further reduced, survival of neutrophils treated with IAV and E. coli. As addition of E. coli resulted in greater neutrophil uptake of IAV and greater neutrophil respiratory burst responses to IAV, this study tested whether respiratory burst activation by IAV and E. coli contributes to reducing neutrophil survival. The cell-permeant NADPH oxidase inhibitor, diphenylene iodonium, significantly increased survival of neutrophils treated with either E. coli alone or the combination of IAV and E. coli. In contrast, catalase, which is not cell permeant, did not alter survival of E. coli-and IAV-treated neutrophils. Azide enhanced neutrophil hydrogen peroxide responses to IAV and E. coli, and reduced survival of these cells. These results indicate that co-operative induction of intracellular respiratory burst responses by IAV and E. coli mediates the reduced neutrophil survival caused by these pathogens in vitro.
Introduction
Bacterial superinfections are a major cause of morbidity and mortality during influenza A virus (IAV) epidemics, particularly among the elderly. IAV infection increases susceptibility to bacterial pneumonia, otitis media and meningitis [1] . The mechanisms through which IAV impairs host defences against bacterial infection have not been fully elucidated, but in-vitro and animal studies indicate that IAV-induced depression of neutrophil function is an important predisposing factor [2] . Recent studies also suggest that co-operative effects of IAV and bacteria on neutrophil survival may contribute to the risk of bacterial superinfection. IAV accelerates apoptosis of epithelial cells, neutrophils and monocytes in vitro [3] [4] [5] . Treatment of neutrophils with both IAV and Escherichia coli causes a rapid, marked decline in neutrophil viability [3] . This decline in viable neutrophils was much greater than that observed with either IAV or E. coli alone. Similar results were obtained with the combination of IAV and Streptococcus pneumoniae [6] .
This study was undertaken to characterise the mechanisms through which IAV and E. coli co-operatively reduce neutrophil viability. First, increased annexin-V binding and caspase-3 activation were shown to occur after infection of neutrophils with IAV or E. coli. However, IAV and E. coli did not co-operatively increase caspase-3 activation. In earlier studies IAV was shown to increase neutrophil Fas antigen and Fas ligand expression; however, as in the case of caspase-3 activation, it was not possible to clearly demonstrate co-operative increases in Fas antigen or ligand expression by co-infection with IAV and E. coli [3] . Hence, this study investigated another mechanism to account for the co-operative effects of IAV and E. coli on neutrophil survival and the neutrophil respiratory burst
Virus preparation
Influenza A virus (Phillipines 82 H3N2 strain) was grown in the chorio-allantoic fluid of 10-day-old embryonated hen's eggs and purified on a discontinuous sucrose density gradient, as described previously [10] . Virus stocks were dialysed against PBS divided into small volumes and stored at À808C until used. Haemagglutination titres were determined by dilution of virus samples in PBS followed by addition of thoroughly washed human type O red blood cells. After thawing, the virus stock contained c. 5 3 10 8 plaqueforming units=ml and had a protein concentration of 3.34 ìg=ml by protein assay (BioRad).
Bacterial preparations E. coli (K12 strain) was obtained from the American Type Culture Collection, grown in this laboratory and fixed with formalin for use in the experiments. S. pneumoniae suspensions in PBS were washed three times and sonicated (for three 20-s intervals) to eliminate bacterial aggregates before each experiment. S. pneumoniae was pre-incubated with specific antipneumococcal IgG 32 ìl=100 ìl for 30 min at 378C and rewashed with PBS to remove residual sodium azide.
Assessment of neutrophil viability and percentage of hypodiploid neutrophils
Assessment of neutrophil viability was made after incubation of the cells for 15 min with trypan blue dye. The numbers of neutrophils that did and did not take up the dye were counted with a haemocytometer. Neutrophils that did not take up trypan blue were counted as viable. The percentage viability of neutrophils was obtained by dividing the number of viable cells by the total number of cells (i.e., both those which did and did not take up trypan blue). The percentage of cells with hypodiploid nuclei was assessed by permeabilising the cells and then exposing them to the DNAbinding dye PI. The method was performed with a slight modification of the method described by Nicoletti et al. [11] . Neutrophils were incubated with IAV or bacteria, or both, as described previously [3] . Briefly, neutrophils were incubated with either E. coli (or S. pneumoniae), IAV or a combination of IAV and the bacteria. The final approximate ratio of bacteria: neutrophil was 30:1. After incubation for 1 h at 378C neutrophils were washed, resuspended in RPMI 1640 supplemented with autologous human serum 4%, 20 mmol=L HEPES buffer, L-glutamine 1%, penicillin 50 U=ml and streptomycin 50 ìg=ml, at pH 7.4, and incubated at 378C. After incubation for 5, 10, 18 and 28 h, a fixed volume of cell suspension was removed from the culture and centrifuged at 200 g for 10 min. The pellet was fixed in 1 ml of ice-cold ethanol 70% at 48C for at least 60 min. Fixed cells were then washed with cold PBS with Ca 2þ and Mg 2þ and gently resuspended in 1 ml of PI solution (40 ìg=ml in PBS with Ca 2þ and Mg 2þ ). The cells were finally incubated in the dark at room temperature for 15 min and analysed on a FACScan 2 flow cytometer (Becton Dickinson, San Jose, CA, USA). Forward and side scatter of neutrophils were simultaneously acquired. The red fluorescence due to PI staining of individual cells was collected under FL-2 and plotted against forward scatter. The FL-2 data were registered on a logarithmic scale. Cell debris was excluded from the analysis by appropriate raising of the forward scatter threshold. Five thousand cells of each sample were counted. All measurements were done under the same instrument settings and evaluated with the Lysis II programme.
Measurement of annexin-V binding
Phosphatidylserine exposure was measured by binding of annexin-V-FITC by the protocol outlined in the annexin-V assay kit (Pharmingen, San Diego, CA, USA). The assay was performed as described by Fadeel et al. [9] . Briefly, this involved staining the cells with annexin and PI (5 ìg=ml) before analysis with a FACScan flow cytometer (Becton Dickinson). Five thousand events were collected and analysed with the Cell Quest software (Becton Dickinson). Low fluorescence detritus was gated out before analysis. The percentage of neutrophils that had positive fluorescence and the mean neutrophil fluorescence were measured for each sample.
Fluorometric analysis of caspase-3 activity
Caspase-3 activity was measured in vitro by cleavage of the fluorogenic substrate DEVD-AMC (amino-4-methylcoumarin) with a fluorometric assay kit (Pharmingen). The caspase-3 aldehyde inhibitor Ac-DEVD-CHO was used as a negative control. For preparation of cytoplasmic extracts after incubation for 5 and 18 h, neutrophils were lysed in lysis buffer (Pharmingen). Cell lysates and substrate were combined in a reaction buffer (Pharmingen). AMC release was monitored in a spectrofluorometer at an excitation wavelength of 380 nm and emission wavelength of 440 nm. Relative AMC fluorescence was expressed as the percentage of fluorescence of control cells.
Assays of neutrophil H 2 O 2 production and intracellular calcium release H 2 O 2 production by neutrophils was measured by the fluorescent scopoletin assay as described previously [12] . Intracellular calcium release was measured with Fura-2 AM (Molecular Probes, Eugene, OR, USA) as described previously [10] . Briefly, neutrophils were loaded with Fura-2AM, washed and resuspended in fresh buffer. Baseline and stimulated intracellular calcium values were obtained by measuring the ratio of fluorescence at 340 and 380 nm with a spectrophotofluorometer.
Measurement of viral uptake by neutrophils
Neutrophils were pre-treated with bacteria or bacterial products. Viral uptake was then measured by incubating FITC-labelled IAV with neutrophils, followed by evaluation of cell-associated fluorescence by flow cytometry, as described previously [13] . Bacterial preparations were washed just before use to remove unbound FITC. Fluorescence was measured in the presence of trypan blue to quench extracellular fluorescence.
Statistical methods
Statistical significance was determined by Student's paired t test. A p value <0.05 was considered to indicate a statistically significant difference.
Results

Effects of IAV and E. coli on annexin-V binding by neutrophils
As shown in Table 1 , the combination of IAV and E. coli significantly increased the mean fluorescence of neutrophils stained with annexin-V-FITC after exposure for 5 h. In these samples, 42% of neutrophils were positive for annexin-V binding, compared with 16% or 28%, respectively, for IAV or E. coli alone. Hence, a large proportion of these cells were undergoing early changes of apoptosis (i.e., phosphatidylserine exposure on extracellular membrane).
Effects of IAV and E. coli on caspase-3 activation
Caspase-3 activity, an indicator of apoptosis, increased in neutrophils treated with control buffer alone (i.e., from 6.4 (SEM 1.2) after incubation for 5 h to 15 (SEM 3.7) after 18 h; n ¼ 8; p ,0.05), but treatment with either IAV or E. coli alone resulted in further significant increases (Table 2 ). Maximal caspase-3 activation appeared to occur after exposure for 10 h to IAV or E. coli, or both. Then caspase-3 activity declined so that after 18 h the level was no longer higher than that of buffer-treated neutrophils. Caspase-3 activity in neutrophils treated with the combination of IAV and E. coli was not significantly greater than activity in neutrophils treated with IAV or E. coli alone ( Table 2) . Granulocyte-macrophage colony stimulating factor (GM-CSF) and survival of neutrophils treated with the combination of IAV and E. coli GM-CSF protects neutrophils against constitutive apoptosis, plays an important role in lung and phagocyte physiology [14] and modulates interactions of IAV with neutrophils [15] . As shown in Fig. 1a , treatment of neutrophils with IAV or E. coli, or both, caused a marked decline in the number of surviving neutrophils after 18 or 28 h, as compared with neutrophils treated with control buffer alone. As previously reported, the combination of IAV and E. coli caused a significantly greater reduction in surviving neutrophils than either IAV or E. coli alone. Addition of GM-CSF did not improve survival of neutrophils treated with the combination of IAV and E. coli. In fact, after 28 h there were significantly fewer surviving cells in samples treated with IAV, E. coli and GM-CSF as compared with those treated with IAV and E. coli. The percentage of viable neutrophils also showed that GM-CSF worsened survival of neutrophils treated with IAV and E. coli (Fig. 1b) .
Effects of E. coli on neutrophil uptake of IAV An earlier study reported that treatment of neutrophils with IAV increases subsequent uptake of E. coli [3] . Treatment of neutrophils with E. coli also increased uptake of FITC-labelled IAV by the cells (Table 3 ). In contrast, S. pneumoniae did not significantly increase uptake of IAV by neutrophils. The effect of E. coli could not be attributed to E. coli-derived LPS alone, as purified LPS did not increase IAV uptake (Table 3) . A previous study demonstrated that GM-CSF increases neutrophil uptake of IAV [15] . However, GM-CSF did not cause a significantly greater increase in IAV uptake when added along with IAV and E. coli (Table 3) .
Evidence for a role of respiratory burst activation in co-operative induction of apoptosis by IAV and E. coli
Previous studies have also demonstrated that the combination of IAV and E. coli triggers a greater respiratory burst response than either agent alone [3] . Hence, agents that inhibit or enhance the respiratory burst were tested for their ability to affect the survival of neutrophils treated with IAV or E. coli, or both. Pretreatment with DPI, a cell-permeant inhibitor of NADPH oxidase activation, fully inhibited H 2 O 2 responses and reduced intracellular calcium responses of neutrophils treated with IAV and E. coli (Table 4) . DPI significantly reduced the development of hypodiploid neutrophils in cultures treated with E. coli alone or the combination of IAV and E. coli (Fig. 2 ) such that these cultures were identical to controls. DPI did not significantly alter the viability of control neutrophils or neutrophils treated with IAV alone (data not shown).
Although catalase blocks detectable H 2 O 2 in the extracellular media of neutrophils stimulated with IAV, it does not inhibit chemiluminescent responses to the virus [16] . Thus, the IAV-induced respiratory burst response largely originates at an intracellular location and is not inhibited by catalase because catalase is not cell permeant. Catalase also did not inhibit the generation of hypodiploid neutrophils in cultures treated with IAV and E. coli. The mean percentages of hypodiploid neutrophils after 18 and 28 h were 32 (SEM 14) and 55 (SEM 18), respectively, in the absence of catalase and 30 (SEM 11) and 63 (SEM 15), respectively, in the presence of catalase (n ¼ 4).
Azide, a cell-permeant inhibitor of catalase and myeloperoxidase which enhances detectable H 2 O 2 release from IAV-treated neutrophils [16] , also increased H 2 O 2 release after stimulation with E. coli or the combination of IAV and E. coli. The response to E. coli or the combination of IAV and E. coli was increased by 67 (SEM 14)% and 50 (SEM 7)%, respectively (n ¼ 4; p ,0.005 for each). Azide also significantly increased the percentage of hypodiploid cells in samples treated with IAV and E. coli (Fig. 3) but not in samples maintained in control buffer alone (Fig. 3) .
Discussion
In previous studies, incubation with IAV or E. coli alone caused an acceleration of neutrophil apoptosis [3, 7] , and this was increased on incubation with both IAV and E. coli. Also, initial studies at this laboratory demonstrated that either IAV or E. coli increased Fas antigen expression on neutrophils and IAV caused significantly increased Fas ligand expression on neutrophils [3] . However, the combination of IAV and E. coli did not clearly increase Fas antigen or Fas ligand expression to a greater extent than either pathogen alone.
In searching for the mechanisms of the co-operative adverse effect of IAV and E. coli on neutrophil Table 4 . Effect of DPI on neutrophil H 2 O 2 production or intracellular calcium rise in response to IAV or the combination of IAV and E. coli survival, this study demonstrated that the combination of these micro-organisms increased annexin-V expression significantly more than either IAV or E. coli alone after incubation for 5 h. These results indicate that IAV and E. coli modify neutrophil membrane phosphatidylserine expression relatively rapidly in vitro and support the concept that these micro-organisms cooperatively induce neutrophil apoptosis. IAV or E. coli also increased caspase-3 activation in neutrophils after 5 h. Therefore, increased annexin-V binding and caspase-3 activation preceded the marked decline in neutrophil viability observed in cultures treated with IAV and E. coli (Fig. 1b) . However, the caspase-3 assay (like the Fas ligand and Fas antigen assays noted above) did not show co-operative effects of IAV and E. coli. Hence, mechanisms other than Fas signalling or caspase-3 activation appear to be involved in the cooperative induction of apoptosis by IAV and E. coli.
The study next attempted to modulate survival of neutrophils treated with IAV and E. coli with the antiapoptotic agent GM-CSF, but it caused a further reduction in survival of IAV-and E. coli-treated neutrophils with greater evidence of cell necrosis. Although the mechanism of this effect of GM-CSF is unclear it may relate to its ability to increase neutrophil respiratory burst responses to IAV [15] (see below).
The present study evaluated whether the effects of E. coli on neutrophil uptake of IAV may contribute to cooperative reduction in neutrophil survival caused by IAV and E. coli. A previous study found that IAV increases neutrophil uptake of and respiratory burst responses to E. coli [3] and, as shown in Table 3 , there is also a reciprocal effect through which E. coli increases neutrophil uptake of IAV. Also, it has been shown that the respiratory burst response triggered by IAV occurs mostly at an intracellular location [16] and recent studies have indicated that neutrophil respiratory burst responses (especially those occurring intracellularly [17] ) are an important trigger for neutrophil apoptosis. Therefore, it was speculated that the ability of IAV and E. coli to reciprocally increase their uptake or co-operative enhancement of respiratory burst responses could account for co-operative increases in apoptosis.
The use of several biochemical modulators provided strong evidence for a critical role of intracellular respiratory burst products in mediating the reduction in neutrophil survival caused by the combination of IAV and E. coli. The cell-permeant respiratory burst inhibitor DPI significantly improved the viability of neutrophils treated with E. coli or the combination of IAV and E. coli, without affecting the viability of neutrophils maintained in control buffer. Furthermore, azide, an inhibitor of catalase and peroxidases which is also cell permeant and potentiates H 2 O 2 production in response to these stimuli, markedly potentiated IAVand E. coli-mediated reduction in neutrophil survival (again without altering survival of control neutrophils). Finally catalase, which catalyses the breakdown of H 2 O 2 but which is not able to permeate the cell membrane, did not alter the effects of IAV and E. coli on neutrophils. These results indicate that the ability of E. coli alone or in combination with IAV to reduce neutrophil survival in vitro involves generation of respiratory burst products within the neutrophil. Furthermore, as azide inhibits myeloperoxidase, the effect does not involve products formed by myeloperoxidase (e.g., HOCl À ).
It remains to be determined whether the ability of IAV and bacteria to co-operatively reduce neutrophil survival in vitro is relevant to the clinical observation that IAV predisposes to bacterial superinfections. Although E. coli is not an organism that is commonly isolated from IAV-infected patients who develop bacterial pneumonia, the more relevant S. pneumoniae also markedly reduced neutrophil survival when added along with IAV in vitro through a respiratory burstrelated mechanism [6] . It has been demonstrated in murine models that measures which reduce the production of oxidants reduce the severity and mortality of influenza pneumonia [18] . Investigations should be done to determine whether similar findings would be obtained in models of co-infection with IAV and bacteria.
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